Apitoria Pharma Private LimitedFebruary 15, 2022

FDA 483 - Apitoria Pharma Private Limited - February 15, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apitoria Pharma Private Limited

Record Details

Aurobindo Pharma Ltd. (Unit V) in Sangareddy, India, was cited with five observations during an FDA inspection. The firm demonstrated significant deficiencies in aseptic processing environmental and personnel monitoring, microbiological contamination prevention procedures, and OOS investigations. Additionally, issues were noted with facility design for observation and incomplete batch production records for sterile active pharmaceutical ingredients.

Company: Apitoria Pharma Private Limited
Inspection Date: February 15, 2022
Product Type: Drugs
Office: Center for Veterinary Medicine
Person: Kellia N. Hicks (Investigator)

Open in Dashboard

ID · a2a96815-dbc8-49f1-8248-8b8f140262e7